{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:27:47Z","timestamp":1786577267769,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Glaukos Medical Spain S.L.","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55366-3","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:15:56Z","timestamp":1780413356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond intraocular pressure: introducing a novel glaucoma-specific PROM for evaluating outcomes after IStent inject implantation combined with phacoemulsification cataract surgery"],"prefix":"10.1038","volume":"16","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Mart\u00ednez-de-la-Casa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Parrilla-Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rodr\u00edguez-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Rodr\u00edguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn Mar\u00eda","family":"Carratal\u00e1-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"55366_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1477-7525-1-75","volume":"1","author":"JP Nordmann","year":"2003","unstructured":"Nordmann, J. P., Auzanneau, N., Ricard, S. & Berdeaux, G. Vision related quality of life and topical glaucoma treatment side effects. Health Qual. Life Outcomes. 1, 75. https:\/\/doi.org\/10.1186\/1477-7525-1-75 (2003).","journal-title":"Health Qual. Life Outcomes"},{"key":"55366_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ajo.2011.06.004","volume":"152","author":"R Varma","year":"2011","unstructured":"Varma, R., Lee, P. P., Goldberg, I. & Kotak, S. An assessment of the health and economic burdens of glaucoma. Am. J. Ophthalmol. 152, 515\u2013522. https:\/\/doi.org\/10.1016\/j.ajo.2011.06.004 (2011).","journal-title":"Am. J. Ophthalmol."},{"key":"55366_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ophtha.2014.08.014","volume":"122","author":"FA Medeiros","year":"2015","unstructured":"Medeiros, F. A. et al. Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. Ophthalmology 122, 293\u2013301. https:\/\/doi.org\/10.1016\/j.ophtha.2014.08.014 (2015).","journal-title":"Ophthalmology"},{"key":"55366_CR4","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham, Y. C. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121, 2081\u20132090. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013 (2014).","journal-title":"Ophthalmology"},{"key":"55366_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/ICU.0b013e32832401a9","volume":"20","author":"P Ramulu","year":"2009","unstructured":"Ramulu, P. Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr. Opin. Ophthalmol. 20, 92\u201398. https:\/\/doi.org\/10.1097\/ICU.0b013e32832401a9 (2009).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"55366_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/01.opx.0000134903.13651.8e","volume":"81","author":"KA Turano","year":"2004","unstructured":"Turano, K. A. et al. Association of visual field loss and mobility performance in older adults: Salisbury Eye Evaluation Study. Optom. Vis. Sci. 81, 298\u2013307. https:\/\/doi.org\/10.1097\/01.opx.0000134903.13651.8e (2004).","journal-title":"Optom. Vis. Sci."},{"key":"55366_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2415-13-4","volume":"13","author":"SW van Landingham","year":"2013","unstructured":"van Landingham, S. W. et al. Driving patterns in older adults with glaucoma. BMC Ophthalmol. 13, 4. https:\/\/doi.org\/10.1186\/1471-2415-13-4 (2013).","journal-title":"BMC Ophthalmol."},{"key":"55366_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1167\/iovs.06-0886","volume":"48","author":"SA Haymes","year":"2007","unstructured":"Haymes, S. A. et al. Risk of falls and motor vehicle collisions in glaucoma. Invest. Ophthalmol. Vis. Sci. 48, 1149\u20131155. https:\/\/doi.org\/10.1167\/iovs.06-0886 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"55366_CR9","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1167\/iovs.16-19458","volume":"57","author":"SE Skalicky","year":"2016","unstructured":"Skalicky, S. E. et al. Activity limitation in glaucoma: objective assessment by the Cambridge Glaucoma Visual Function Test. Invest. Ophthalmol. Vis. Sci. 57, 6158\u20136166. https:\/\/doi.org\/10.1167\/iovs.16-19458 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"55366_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2021-egsguidelines","volume":"105","author":"European Glaucoma Society","year":"2021","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br. J. Ophthalmol. 105, 1\u2013169. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-egsguidelines (2021).","journal-title":"Br. J. Ophthalmol."},{"key":"55366_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/03007995.2024.2322048","volume":"40","author":"MF Cordeiro","year":"2024","unstructured":"Cordeiro, M. F. et al. Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma. Curr. Med. Res. Opin. 40, 647\u2013655. https:\/\/doi.org\/10.1080\/03007995.2024.2322048 (2024).","journal-title":"Curr. Med. Res. Opin."},{"key":"55366_CR12","doi-asserted-by":"publisher","first-page":"e0024","DOI":"10.5041\/RMMJ.10345","volume":"9","author":"L Bar-David","year":"2018","unstructured":"Bar-David, L. & Blumenthal, E. Z. Evolution of glaucoma surgery in the last 25 years. Rambam Maimonides Med. J. 9, e0024. https:\/\/doi.org\/10.5041\/RMMJ.10345 (2018).","journal-title":"Rambam Maimonides Med. J."},{"key":"55366_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ogla.2021.03.012","volume":"4","author":"SA Yang","year":"2021","unstructured":"Yang, S. A. et al. Trends and usage patterns of minimally invasive glaucoma surgery in the United States: IRIS\u00ae Registry Analysis 2013\u20132018. Ophthalmol. Glaucoma. 4, 558\u2013568. https:\/\/doi.org\/10.1016\/j.ogla.2021.03.012 (2021).","journal-title":"Ophthalmol. Glaucoma"},{"key":"55366_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2023-egsguidelines","volume":"107","author":"L Abegao Pinto","year":"2023","unstructured":"Abegao Pinto, L. et al. European Glaucoma Society \u2013 a guide on surgical innovation for glaucoma. Br. J. Ophthalmol. 107, 1\u2013114. https:\/\/doi.org\/10.1136\/bjophthalmol-2023-egsguidelines (2023).","journal-title":"Br. J. Ophthalmol."},{"key":"55366_CR15","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/OPTH.S135316","volume":"11","author":"LE Pillunat","year":"2017","unstructured":"Pillunat, L. E., Erb, C., J\u00fcnemann, A. G. & Kimmich, F. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clin. Ophthalmol. 11, 1583\u20131600 (2017).","journal-title":"Clin. Ophthalmol."},{"key":"55366_CR16","unstructured":"Food, U. S. & Administration, D. Glaukos iStent\u00ae Trabecular Micro-Bypass Stent (Models: GTS-100R, GTS-100L) and Inserter (GTS-100i) \u2013 P080030. (2012). Available at: www.accessdata.fda.gov\/cdrh_docs\/pdf8\/P080030a.pdf. Accessed December 24, 2025."},{"key":"55366_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4137\/HSI.S11093","volume":"6","author":"T Weldring","year":"2013","unstructured":"Weldring, T. & Smith, S. M. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv. Insights. 6, 61\u201368. https:\/\/doi.org\/10.4137\/HSI.S11093 (2013).","journal-title":"Health Serv. Insights"},{"key":"55366_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41433-019-0676-8","volume":"34","author":"T Li","year":"2020","unstructured":"Li, T. et al. Patient-reported outcomes measures and patient preferences for minimally invasive glaucoma surgical devices. Eye (Lond). 34, 205\u2013210. https:\/\/doi.org\/10.1038\/s41433-019-0676-8 (2020).","journal-title":"Eye (Lond)"},{"key":"55366_CR19","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1016\/j.ajo.2024.06.002","volume":"266","author":"K Singh","year":"2024","unstructured":"Singh, K. et al. Patient-reported outcomes for minimally invasive glaucoma surgery. Am. J. Ophthalmol. 266, A1\u2013A3. https:\/\/doi.org\/10.1016\/j.ajo.2024.06.002 (2024).","journal-title":"Am. J. Ophthalmol."},{"key":"55366_CR20","doi-asserted-by":"publisher","first-page":"251584142311527","DOI":"10.1177\/25158414231152765","volume":"15","author":"L Jones","year":"2023","unstructured":"Jones, L. et al. Impact of minimally invasive glaucoma surgery on the ocular surface and quality of life in patients with glaucoma. Ther. Adv. Ophthalmol. 15, 25158414231152765. https:\/\/doi.org\/10.1177\/25158414231152765 (2023).","journal-title":"Ther. Adv. Ophthalmol."},{"key":"55366_CR21","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1038\/s41433-023-02532-w","volume":"37","author":"A Safitri","year":"2023","unstructured":"Safitri, A. et al. Treatment expectations in glaucoma: what matters most to patients? Eye (Lond). 37, 3446\u20133454. https:\/\/doi.org\/10.1038\/s41433-023-02532-w (2023).","journal-title":"Eye (Lond)"},{"key":"55366_CR22","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione, C. M. et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch. Ophthalmol. 119, 1050\u20131058. https:\/\/doi.org\/10.1001\/archopht.119.7.1050 (2001).","journal-title":"Arch. Ophthalmol."},{"key":"55366_CR23","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","volume":"393","author":"G Gazzard","year":"2019","unstructured":"Gazzard, G. et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet 393, 1505\u20131516. https:\/\/doi.org\/10.1016\/S0140-6736(18)32213-X (2019).","journal-title":"Lancet"},{"key":"55366_CR24","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/bmj.n1014","volume":"373","author":"AJ King","year":"2021","unstructured":"King, A. J. et al. Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS). BMJ 373, 1014. https:\/\/doi.org\/10.1136\/bmj.n1014 (2021).","journal-title":"BMJ"},{"key":"55366_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/bjo-2021-320722","volume":"107","author":"A Rabiolo","year":"2023","unstructured":"Rabiolo, A., Barton, K. & McNaught, A. I. Patient-reported outcome measures should not be the primary outcome in glaucoma clinical trials of disease modification. Br. J. Ophthalmol. 107, 3\u20135. https:\/\/doi.org\/10.1136\/bjo-2021-320722 (2023).","journal-title":"Br. J. Ophthalmol."},{"key":"55366_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ophtha.2018.09.034","volume":"126","author":"L Jones","year":"2019","unstructured":"Jones, L. et al. Are patient self-reported outcome measures sensitive enough to be used as end points in clinical trials? Evidence from the United Kingdom Glaucoma Treatment Study. Ophthalmology 126, 682\u2013689. https:\/\/doi.org\/10.1016\/j.ophtha.2018.09.034 (2019).","journal-title":"Ophthalmology"},{"key":"55366_CR27","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1136\/bjophthalmol-2018-313401","volume":"103","author":"BB Kulkarni","year":"2019","unstructured":"Kulkarni, B. B., Leighton, P. & King, A. J. Exploring patients\u2019 expectations and preferences of glaucoma surgery outcomes to facilitate healthcare delivery and inform future glaucoma research. Br. J. Ophthalmol. 103, 1850\u20131855. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313401 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"55366_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ogla.2019.07.005","volume":"2","author":"JT Le","year":"2019","unstructured":"Le, J. T. et al. Identifying outcomes that are important to patients with ocular hypertension or primary open-angle glaucoma: a qualitative interview study. Ophthalmol. Glaucoma. 2, 374\u2013382. https:\/\/doi.org\/10.1016\/j.ogla.2019.07.005 (2019).","journal-title":"Ophthalmol. Glaucoma"},{"key":"55366_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ogla.2020.05.003","volume":"3","author":"AK Bicket","year":"2020","unstructured":"Bicket, A. K. et al. Priorities and treatment preferences among surgery-naive patients with moderate to severe open-angle glaucoma. Ophthalmol. Glaucoma. 3, 377\u2013383. https:\/\/doi.org\/10.1016\/j.ogla.2020.05.003 (2020).","journal-title":"Ophthalmol. Glaucoma"},{"key":"55366_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ogla.2021.04.011","volume":"5","author":"BC Stagg","year":"2022","unstructured":"Stagg, B. C. et al. The burden of caring for and treating glaucoma: the patient perspective. Ophthalmol. Glaucoma. 5, 32\u201339. https:\/\/doi.org\/10.1016\/j.ogla.2021.04.011 (2022).","journal-title":"Ophthalmol. Glaucoma"},{"key":"55366_CR31","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1167\/iovs.10-7134","volume":"52","author":"GL Spaeth","year":"2011","unstructured":"Spaeth, G. L. Valid relevance in medical practice: the inadequacy of the linear model of health and disease: the Weisenfeld lecture. Invest. Ophthalmol. Vis. Sci. 52, 6250\u20136256. https:\/\/doi.org\/10.1167\/iovs.10-7134 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"55366_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/eye.2011.45","volume":"25","author":"S Vandenbroeck","year":"2011","unstructured":"Vandenbroeck, S. et al. Patient-reported outcomes in glaucoma: a systematic review. Eye (Lond). 25, 555\u2013577. https:\/\/doi.org\/10.1038\/eye.2011.45 (2011).","journal-title":"Eye (Lond)"},{"key":"55366_CR33","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s11136-010-9831-1","volume":"20","author":"J Che Hamzah","year":"2011","unstructured":"Che Hamzah, J. et al. Choosing appropriate patient-reported outcomes instrument for glaucoma research: a systematic review of vision instruments. Qual. Life Res. 20, 1141\u20131158. https:\/\/doi.org\/10.1007\/s11136-010-9831-1 (2011).","journal-title":"Qual. Life Res."},{"key":"55366_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/IJG.0b013e318287ac11","volume":"24","author":"J Khadka","year":"2015","unstructured":"Khadka, J. et al. Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters. J. Glaucoma. 24, 12\u201319. https:\/\/doi.org\/10.1097\/IJG.0b013e318287ac11 (2015).","journal-title":"J. Glaucoma"},{"key":"55366_CR35","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/OPX.0000000000000992","volume":"93","author":"J Khadka","year":"2016","unstructured":"Khadka, J. et al. Methods to develop the Eye-tem Bank to measure ophthalmic quality of life. Optom. Vis. Sci. 93, 1485\u20131494. https:\/\/doi.org\/10.1097\/OPX.0000000000000992 (2016).","journal-title":"Optom. Vis. Sci."},{"key":"55366_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.2017.21903","volume":"319","author":"M Calvert","year":"2018","unstructured":"Calvert, M. et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension. JAMA 319, 483\u2013494. https:\/\/doi.org\/10.1001\/jama.2017.21903 (2018).","journal-title":"JAMA"},{"key":"55366_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/PROM.S162802","volume":"10","author":"T Braithwaite","year":"2019","unstructured":"Braithwaite, T. et al. The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice. Patient Relat. Outcome Meas. 10, 9\u201324. https:\/\/doi.org\/10.2147\/PROM.S162802 (2019).","journal-title":"Patient Relat. Outcome Meas."},{"key":"55366_CR38","doi-asserted-by":"publisher","first-page":"e1002370","DOI":"10.1371\/journal.pmed.1002370","volume":"14","author":"S Cruz Rivera","year":"2017","unstructured":"Cruz Rivera, S. et al. Assessing the impact of healthcare research: a systematic review of methodological frameworks. PLoS Med. 14, e1002370. https:\/\/doi.org\/10.1371\/journal.pmed.1002370 (2017).","journal-title":"PLoS Med."},{"key":"55366_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ophtha.2010.07.007","volume":"118","author":"TW Samuelson","year":"2011","unstructured":"Samuelson, T. W. et al. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 118, 459\u2013467. https:\/\/doi.org\/10.1016\/j.ophtha.2010.07.007 (2011).","journal-title":"Ophthalmology"},{"key":"55366_CR40","unstructured":"Food, U. S. & Administration, D. Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical (MIGS) Devices \u2013 Guidance for Industry and Food and Drug Administration Staff. (2025). Available at: https:\/\/www.fda.gov\/medical-devices. Accessed December 27, 2025."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55366-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55366-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55366-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T22:53:04Z","timestamp":1786575184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55366-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55366"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55366-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.JMC: Grants: Santen, Ivantis, Abbvie, Viatris, Glaukos, Thea, Omikron, Nova Eye Medical, Vialase. Consultant: Abbvie, Santen, Alcon, Viatris, Novartis, Thea, B&L, Glaukos, AJL, Visufarma, Angelini. Speaker: Abbvie, Santen, Alcon, Viatris, Novartis, Thea, B&L, Glaukos, iCare, Angelini, Nova Eye Medical.The rest of the authors do not have any conflict to declare.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25159"}}